SCHEMBL6705357

SCHEMBL6705357

CCCCCCCCCCCCCCCCCCOc1ccc(C(=O)c2ccc(OCCCCCCCCCCCCCCCCCC)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.77
TSHR P16473 1/20 0.77
PLA2G4B P0C869 6/20 0.75
RARB P10826 3/20 0.71
PLA2G4A P47712 1/20 0.67
GAA P10253 1/20 0.65
NR5A1 Q13285 1/20 0.65
THRA P10827 2/20 0.63
THRB P10828 2/20 0.63
L3MBTL1 Q9Y468 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8769734 1.00 TP53 (0.77) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL15154875 1.00 TP53 (0.77) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL533825 1.00 TP53 (0.77) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL1623628 1.00 TP53 (0.77) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL18302060 1.00 TP53 (0.77) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL17203727 0.98 TP53 (0.74) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL8769969 0.94 TP53 (0.68) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL6648277 0.93 TP53 (0.73) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL18774788 0.93 TP53 (0.73) TP53TSHRPLA2G4BRARBPLA2G4A
SCHEMBL534947 0.93 TP53 (0.73) TP53TSHRPLA2G4BRARBPLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040116685-A1 Method for solution phase synthesis of oligonucleotides PROLIGO LLC 2004-06-17 US disclosed
EP-0996627-A4 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES PROLIGO L L C (US) 2002-01-02 EP disclosed
US-6262251-B1 PRODUCT ANCHORED SEQUENCIAL SYNTHESIS (PASS); AN ANCHOR GROUP ATTACHED TO THE 5' END OF THE GROWING OLIGONUCLEOTIDE PRODUCT ALLOWS THE COUPLED PRODUCT TO BE SEPARATED FROM UNREACTED STARTING MATERIALS PROLIGO LLC 2001-07-17 US disclosed
EP-0979233-A4 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO L L C (US) 2001-03-21 EP disclosed
EP-0996627-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES Proligo L.L.C. (US) 2000-05-03 EP disclosed
EP-0979233-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NeXstar Pharmaceuticals, Inc. (US) 2000-02-16 EP disclosed
US-6001966-A REACTING N-TERMINAL PROTECTED AMINO ACID WITH PEPTIDE STARTING MATERIAL FORMING A PEPTIDE PRODUCT, PARTITIONING FROM UNREACTED MATERIAL AND REAGENTS BASED ON PRESENCE OF N-TERMINAL BLOCKING/ANCHORING GROUP PROLIGO LLC (US) 1999-12-14 US disclosed
US-5874532-A USING A N-TERMINAL PROTECTED AMINO ACID MONOMER NEXSTAR PHARMACEUTICALS, INC. (US) 1999-02-23 US disclosed
WO-1998047910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO LLC (US) 1998-10-29 WO disclosed
EP-0863910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NeXstar Pharmaceuticals, Inc. (US) 1998-09-16 EP disclosed
WO-1998030578-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES PROLIGO LLC (US) 1998-07-16 WO disclosed
WO-1997014706-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NEXSTAR PHARMACEUTICALS, INC. (US) 1997-04-24 WO disclosed
US-4495311-A METAL CHELATES OR SALTS AND BENZOYL COMPOUNDS AS ADDIVES PRINCETON POLYMER LABORATORIES, INC. (US) 1985-01-22 US disclosed
US-3981856-A BIODEGRADATION, ADDITION POLYMERS PRINCETON POLYMER LABORATORIES, INCORPORATED (US) 1976-09-21 US disclosed